Mark Hyman, MD · 2026-08-12 · Mark Hyman (host), Tyna Moore

What We Got Wrong About GLP-1s (And What's Actually Right)

44 research-tied claims examined: 3 contradicted 4 overstated 6 context 24 supported 7 unverified

Overstated

A study showed that statin medications reduce endogenous GLP-1 production by 50%.

"We have a study from I think last year showing that statin drugs decreased endogenous GLP-1 production by 50%." (said at 0:09:28)

The claim generalizes acute preclinical and in vitro findings to clinical human physiology. A translational study investigating HMGCR inhibition found that rosuvastatin acutely inhibited GLP-1 secretion in GLUTag enteroendocrine cell models and acutely suppressed postprandial GLP-1 in mice. However, in the same study, chronic statin treatment in mice actually increased postprandial GLP-1 levels, and in human cohort data (MDCS-CC, n = 3,734), statin use was not associated with reduced GLP-1 in non-diabetic individuals and was associated with higher fasting GLP-1 in individuals with type 2 diabetes. Additionally, a randomized crossover trial in healthy men found that atorvastatin increased postprandial GLP-1 concentrations compared with placebo.

partial: HMGCR and Rosuvastatin Regulates GLP-1 Secretion and Expression-A Translational Study. (The Journal of clinical endocrinology and metabolism 2026) · cited 2x in the literature
"Rosuvastatin treatment or 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (Hmgcr) knockdown (KD) reduced GLP-1 secretion and increased Gcg messenger RNA in GLUTag cells. Rosuvastatin acutely reduced postprandial GLP-1 secretion, whereas chronic rosuvastatin treatment in mice caused hyperglycemia and increased postprandial GLP-1 levels." (abstract, results, passage verified)
pubmed full study (doi)
contradicts: Metabolic, enterohepatic and gut microbial effects of atorvastatin in healthy men. (Endocrine connections 2026) · cited 2x in the literature
"Postprandial plasma concentrations of the gut-derived incretin hormones glucose-dependent insulinotropic polypeptide and glucagon-like peptide 1 were increased after atorvastatin treatment compared with placebo." (abstract, results, passage verified)
pubmed full study (doi)

0:09:37 Mark Hyman (host)overstatedhigh

Statin medications increase insulin resistance and significantly elevate the risk of developing diabetes.

"when you look at statins, they increase insulin resistance and increase the risk of diabetes significantly." (said at 0:09:37)

Large-scale randomized controlled trials and meta-analyses confirm that statin therapy causes a small, dose-dependent increase in insulin resistance and incident diabetes, but the magnitude of this effect is modest rather than large. In an individual participant data meta-analysis of over 150,000 trial participants, low-to-moderate intensity statins were associated with a 10% relative increase in new-onset diabetes (1.3% vs 1.2% per year), and high-intensity statins with a 36% relative increase (4.8% vs 3.5% per year). This risk is driven by a very small average rise in blood glucose (~0.04 mmol/L) and HbA1c (0.06% to 0.08%), primarily tipping individuals who already had baseline pre-diabetes or borderline glycemic markers over the diagnostic threshold.

supports: Effects of statin therapy on glycemic control and insulin resistance: A systematic review … (European journal of pharmacology 2023) · cited 58x in the literature
"In individuals with normal glycemic control, statin increased HbA1c (MD 1.33%, 95% CI 1.31-to-1.35) and HOMA-IR (MD 0.49, 95% CI 0.41-to-0.58) in comparison to the placebo groups." (abstract, results, passage verified)
pubmed full study (doi)
partial: Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in la… (The lancet. Diabetes & endocrinology 2024) · cited 151x in the literature
"Statins cause a moderate dose-dependent increase in new diagnoses of diabetes that is consistent with a small upwards shift in glycaemia, with the majority of new diagnoses of diabetes occurring in people with baseline glycaemic markers that are close to the diagnostic threshold for diabetes." (abstract, conclusions, passage verified)
pubmed full study (doi)

0:33:45 Tyna Mooreoverstatedmoderate

Published research demonstrates that incorporating strength training during weight loss leads to appreciable weight loss retention.

"utilizing strength training during a weight loss journey leads to appreciable weight loss retention." (said at 0:33:45)

While resistance training during diet-induced weight loss reliably preserves lean body mass, muscle strength, and resting metabolic rate, clinical trials and systematic reviews indicate that its specific effect on long-term weight loss retention (preventing weight regain) is modest and inconsistent. Guideline syntheses highlight that substantial aerobic exercise volume (>150–300 minutes/week) is the primary physical activity modality associated with mitigating weight regain, whereas evidence for resistance training directly preventing weight regain remains uncertain.

contradicts: Physical activity in the management of obesity in adults: A position statement from Exerci… (Journal of science and medicine in sport 2021) · cited 50x in the literature
"Research evidence indicates that >150 min but preferably 300 min per week of aerobic activity of at least moderate intensity is required to prevent weight and adiposity gain, and at least the upper end of this range of activity to prevent weight regain after weight loss. ... The impact of high-intensity physical activity and resistance exercise for weight management is uncertain." (abstract, results, passage verified)
pubmed full study (doi)
context: Physical activity and exercise for weight loss and maintenance in people living with obesi… (Reviews in endocrine & metabolic disorders 2023) · cited 93x in the literature
"Based on data from controlled trials with randomization after prior weight loss, the evidence for weight maintenance with exercise training is as yet not conclusive, although retrospective analyses point to the value of relatively high-volume exercise in this regard. Resistance (i.e. muscle-strengthening) training is specifically advised for lean mass preservation during weight loss." (abstract, results and conclusions, passage verified)
pubmed full study (doi)

0:51:45 Tyna Mooreoverstatedvery low

Elevated lipopolysaccharide (LPS) levels promote adipose cell expansion, obesity, and type 2 diabetes via inflammation and insulin resistance.

"and it also has a huge impact on our lipopolysaccharide levels, and when those elevate, they cause your fat cells to expand and to get bigger... and LPS is what drives obesity and type 2 diabetes." (said at 0:51:45)

Preclinical animal research demonstrates that experimental elevation of bacterial lipopolysaccharide (LPS)—termed metabolic endotoxemia—can induce adipose tissue weight gain, macrophage infiltration, low-grade inflammation, and hepatic insulin resistance comparable to a high-fat diet. However, asserting that LPS is definitively what drives obesity and type 2 diabetes overstates the evidence, as obesity and type 2 diabetes in humans are complex, multifactorial disorders where metabolic endotoxemia is considered an associated mechanism or contributing factor rather than the singular primary cause.

partial: Metabolic endotoxemia initiates obesity and insulin resistance. (Diabetes 2007) · cited 6569x in the literature
"When metabolic endotoxemia was induced for 4 weeks in mice through continuous subcutaneous infusion of LPS, fasted glycemia and insulinemia and whole-body, liver, and adipose tissue weight gain were increased to a similar extent as in high-fat-fed mice. In addition, adipose tissue F4/80-positive cells and markers of inflammation, and liver triglyceride content, were increased. Furthermore, liver, but not whole-body, insulin resistance was detected in LPS-infused mice." (abstract, results, passage verified)
pubmed full study (doi)

Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.